Keybanc analyst Sean Eastman downgrades EMCOR Gr (NYSE:EME) from Overweight to Sector Weight.
Keybanc Downgrades EMCOR Gr to Sector Weight
Keybanc analyst Sean Eastman downgrades EMCOR Gr (NYSE:EME) from Overweight to Sector Weight.
Related Posts
Galmed Announces Allowance Of New Patent For Aramchol For The Treatment Of Pulmonary And Dermal Fibrosis
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and fibrotic diseases announced today the allowance of a Japanese patent
Party City Holdco Files For Chapter 11 Bankruptcy; Secures $150M Financing Commitment
Party City Holdco Inc (NYSE:PRTY) has filed voluntary Chapter 11 petitions for relief in the U.S. Bankruptcy Court for the Southern…